News Info Home > News Info
Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for s...
Time:2026/7/13 23:31:00
Recently, we have reported a multifunctional co-delivery system with size-switchable and enhanced stroma-penetrating capacities. This delivery system can deliver distinct glutamine metabolic regulators deep into pancreatic ductal adenocarcinoma (PDAC) lesions...
+More
Time:2026/7/13 23:34:49
AI-Optimized 3D-Printed Dual-Layer Implant: Resolving Chemo-Immunotherapy Sequen...
Time:2026/7/13 23:08:52
Colorectal cancer peritoneal metastasis (CCPM) poses a significant clinical challenge due to the widespread dissemination of lesions, the difficulty of local treatment and a markedly immunosuppressive microenvironment. Although conventional hyperthermic intra...
Reengineered Albumin-Paclitaxel Nanoparticles Remodeling Tumor Cell Death Pathwa...
Time:2026/5/7 22:30:57
Triple-negative breast cancer (TNBC) represents a formidable clinical challenge due to its poor prognosis and high metastatic propensity. Although paclitaxel chemotherapy remains a cornerstone of treatment, it can paradoxically promote metastasis by facilitat...
Shutting Down the ‘Language Encoder’: A Pathogen-Derived Nano-Interferer Disru...
Time:2025/12/3 13:25:00
Aberrant enhancement of terminal sialylation in glioblastoma (GBM) has been established as a critical metabolic determinant for maintaining membrane receptor homeostasis, constructing high-throughput intercellular communication networks, and ultimately promot...
Room 713, Scientific research building, School of pharmacy, Fudan university, No. 826, Zhangheng Road, Pudong new area, Shanghai Zip:201203 Tel 021-50772670 Copy Right @ 2026 Jiang Group. All rights reserved.
X